Inhaled nitric oxide perioperative and in intensive care units;Le monoxyde d'azote inhalé en période périopératoire et en réanimation

Annales Francaises d'Anesthesie et de Reanimation

Volumn 21, Issue 7, 2002, Pages 581-590

  Robin, E ^a   Haddad, E ^a   Vallet, B ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

ARDS; Cardiac surgery; Cardiopulmonary bypass; Heart transplantation; Hypoxaemia; Inhaled NO; Neonate; Nitric oxide; NO; Pulmonary hypertension

Indexed keywords

NITRIC OXIDE;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL MODEL; CARDIOPULMONARY BYPASS; CLINICAL PROTOCOL; CLINICAL TRIAL; EXTRACORPOREAL OXYGENATION; HEART SURGERY; HEART TRANSPLANTATION; HUMAN; HYPOXEMIA; INTENSIVE CARE UNIT; MULTICENTER STUDY; NONHUMAN; POSITIVE END EXPIRATORY PRESSURE; PULMONARY HYPERTENSION; RAT; REVIEW; TREATMENT INDICATION;

EID: 0036338849     PISSN: 07507658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0750-7658(02)00677-9     Document Type: Review

References (62)

1. The L-arginine nitric oxide pathway
2. Inhaled nitric oxide. A selective vasodilatator reversing hypoxic pulmonary vasoconstriction
3. Inhaled nitric oxide. A selective pulmonary vasodilatator of heparin-protamin vasoconstriction in sheep
4. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension
5. Use of inhaled nitric oxide perioperatively and in intensive care patients
6. Cardiovascular effects of inhaled nitric oxide in patients with left ventricular dysfunction
7. Inhaled nitric oxide in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance
8. Response to inhaled nitric oxide in patients with acute right heart syndrome
9. Effect of inhaled nitric oxide on right ventricular function in adult respiratory distress syndrome
10. Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass
11. Vasodilatator therapy after heart transplantation: Effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside
12. Inhaled nitric oxide reduces pulmonary vascular resistance more than prostaglandin E (1) during heart tranplantation
13. Selective pulmonary vasodilatation in cardiac surgical patient
14. Variable response to inhaled nitric oxide after cardiac surgery
15. Randomized, double-bind study trial of inhaled nitric oxide in LVAD recipients with pulmonary hypertension
16. Pharmacologic reduction of transplantation pulmonary vascular resistance predict outcome after pediatric heart transplantation
17. Inhaled nitric oxide in congenital heart disease
18. The effects of inhaled nitric oxide on postoperative pulmonary hypertension in infants and children undergoing surgical repair of congenital heart disease
19. Nitric oxide might reduce the need for extracorporeal support in children with critical postoperative pulmonary hypertension
20. Inhaled nitric oxide reduces human lung allograft dysfunction
21. The acute respiratory distress syndrome
22. Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome
23. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome
24. The American-European Consensus Conference on ARDS: Definitions, mechanisms, relevant outcomes and clinical trial coordination
25. Inhaled nitric oxide in adult respiratory distress syndrome
26. Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome
27. Inhaled nitric oxide in acute respiratory failure: Dose-response curves
28. Inhaled nitric oxide in acute respiratory distress syndrome with and without septic shock: A dose-response study
29. Inhaled nitric oxide versus conventionnal therapy: Effects on oxygenation in ARDS
30. Factors influencing cardiopulmonary effects of inhaled nitric oxide in acute respiratory failure
31. Additive effect of nitric oxide inhalation on the benefit of the prone position in the adult respiratory distress syndrome
32. Short-term effect of inhaled nitric oxide and prone positioning on gas exchange in patients with severe acute respiratory distress syndrome
33. Intravenous almitrine combined with inhaled nitric oxide for acute respiratory distress syndrome
34. Inhaled nitric oxide, almitrine infusion or their coadministration as a treatment of hypoxemic focal lung lesions
35. The cGMP phosphodiesterase inhibitor zaprinast enhances the effect of nitric oxide
36. Effects of intravenous zaprinast and inhaled nitric oxide on pulmonary hemodynamics and gas exchange in an ovine model of acute respiratory distress syndrome
37. Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome, Results of a randomized phase II trial. Inhaled nitric oxide in ARDS study group
38. Inhalation of nitric oxide in acute lung injury: Results of a European multicentre study
39. Results of the french prospective multicentric randomized double blind placebo-controlled trial on inhaled nitric oxide (NO) in ARDS
40. Response to nitric oxide in early acute lung injury
41. Hemodynamic and gas exchange responses to infusion of acetylcholine and inhalation of nitric oxide in patients with chronic obstructive lung disease and pulmonary hypertension
42. Effect of inhaled nitric oxide on hemodynamics and Va/Q inequalities in patients with chronic obstructive pulmonary disease
43. Bronchodilatator action of inhaled nitric oxide in guinea pigs
44. Hemodynamic and gas exchange responses to inhalation of nitric oxide in patients with the acute respiratory distress syndrome and in hypoxemic patients with chronic obstructive pulmonary disease
45. Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn
46. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn
47. Inhaled nitric oxide and persitent pulmonary hypertension of the newborn
48. Inhaled nitric oxide in full-term and nearly fullterm infants with hypoxic respiratory failure
49. Inhaled nitric oxide in sickle cell disease with acute chest syndrome
50. Inhaled nitric oxide: Technical aspects of administration and monitoring
51. Distribution of inhaled nitric oxide during sequential and continuous administration into the inspiratory limb of the ventilator
52. Life-threatening effects of discontinuing inhaled nitric oxide in severe respiratory failure
53. Rebound pulmonary hypertension on withdrawal from inhaled nitric oxide
54. The incidence and pathogenesis of cardiopulmonary deterioration after abrupt withdrawal on inhaled nitric oxide
55. The use, and misuse, of exogenous endothelial-derived vasodilatators in acute respiratory failure
56. Nitric oxide-induced inhibition of lung endothelial cell nitric oxide synthase via interaction with allosteric thiols: Role of thioredoxin in regulation of catalytic activity
57. Toxicologie du monoxyde d'azote
58. Nitric oxide inhalation decreases pulmonary platelet and neutrophil sequestration during extracorporeal circulation in the pig
59. Nitric oxide inhalation inhibits platelet aggregation and platelet-mediated pulmonary thrombosis in rats
60. Inhaled nitric oxide inhibits human platelet aggregation, P-selectin expression, and fibrinogen binding in vitro and in vivo
61. Inhibition of platelet aggregation by inhaled nitric oxide in patients with adult respiratory distress syndrome
62. Introduction: Une autorisation transitoire d'utilisation pour le monoxyde d'azote (NO) inhalé